IperionX responds to short seller, highlights U.S. contracts and growth plans

IperionX hits back at a short seller report, highlighting fresh U.S. defence contracts and its growth outlook.

| More on:
An old man with wavy white hair folds his arms in a stubborn gesture as he stands defiantly in an outdoor setting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • IperionX completed the Virginia Titanium Manufacturing Campus commissioning with enhanced production capacity and secured over US$59 million in U.S. Department of Defense awards to expand operations.
  • The company addressed a short seller report, emphasising its robust data-security and compliance controls, along with substantial backing and validation from U.S. Government agencies.
  • IperionX is focused on scaling its operations, increasing titanium production capacity, and advancing the Titan Critical Minerals Project, aiming to penetrate high-growth markets with its innovative titanium products.

The IperionX Ltd (ASX: IPX) share price is in focus today after the company issued a detailed response to a short seller report, reaffirming its operational progress and robust U.S. Government support for its titanium manufacturing technologies.

What did IperionX report?

  • Completion of the Virginia Titanium Manufacturing Campus commissioning, with nameplate production capacity raised to 200 tonnes per annum (tpa)
  • Secured over US$59 million in recent U.S. Department of Defense awards to help expand operations and advance feasibility studies
  • Held US$79.2 million cash and equivalents at 30 September 2025, plus access to US$43 million in obligated government funding
  • Received U.S. Army SBIR Phase III contract for up to US$99 million in procurement, with the first task order already issued
  • Secured commercial agreements with Ford, Panerai, and the U.S. Army for titanium product supply
  • Advancing a pipeline of over 90 active customer programs and 22 final-stage commercial negotiations

What else do investors need to know?

IperionX addressed the short seller's report directly, noting that Spruce Point Capital did not contact or visit management or operational sites before its release. The company emphasised its strong data-security, intellectual property, and compliance controls, meeting U.S. Government requirements.

The business highlighted ongoing support and validation from multiple U.S. Government agencies, including ARPA-E and the Department of Defense, with several funding and production contracts supporting its expansion and commercialisation efforts.

IperionX is scaling its Virginia operations with plans to boost titanium production from the current 200 tpa to approx. 1,400 tpa by mid-2027. Meanwhile, the Titan Critical Minerals Project in Tennessee is progressing towards a definitive feasibility study.

What's next for IperionX?

Management's near-term priorities include increasing production capacity at the Virginia facility, delivering on government task orders, and lowering costs through process improvements. The Titan Project aims to reach shovel-ready status by mid-2026, potentially supplying rare earths, titanium, and zircon to support U.S. critical mineral security.

Looking further ahead, IperionX is targeting high-growth end markets with its low-cost, lower-carbon titanium components, expanding its high-value product offering for sectors such as defence, automotive, and electronics.

IperionX share price snapshot

IperionX shares have risen 38% over the past 12 months, significantly outperforming the S&P/ASX 200 Index (ASX: XJO) which has increased 4% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Share Market News

A man clenches his fists in excitement as gold coins fall from the sky.
Gold

This ASX 300 gold stock is rocketing 27% amid takeover bidding war

This gold miner has received a new takeover offer.

Read more »

Two strong women battle it out in the boxing ring.
Opinions

Rio Tinto versus BHP shares: One I'd buy and one I'd sell

Here’s what to expect over the next 12 months.

Read more »

A man in a suit and glasses guffaws at his computer screen in bewilderment.
Share Market News

Perseus Mining launches superior offer for Predictive Discovery shares

Perseus Mining has offered to acquire all shares in Predictive Discovery, aiming to expand in African gold with a premium…

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Morgans gives its verdict on A2 Milk and these ASX shares

Is the broker bullish or bearish on these names?

Read more »

Close up of woman using calculator and laptop for calculating dividends.
Share Market News

Transurban announces 34c interim distribution and reaffirms FY26 guidance

Transurban declared a 34 cent interim distribution and confirmed FY26 guidance; here's what investors need to know.

Read more »

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Wednesday

It looks set to be a decent session for Aussie investors today.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Healthcare Shares

3 reasons to buy this $12 billion ASX 200 stock today

Market experts see 40% upside.

Read more »

Young lady in JB Hi-Fi electronics store checking out laptops for sale
Broker Notes

Does Macquarie rate Harvey Norman shares a buy, hold or sell?

The broker has downgraded its view on this consumer discretionary stock.

Read more »